Gynaecomastia surgery under local anaesthesia is an option increasingly offered by specialist surgeons across the UK, and understanding when it is appropriate can help men make informed decisions about their care. Gynaecomastia — the benign enlargement of male breast tissue — may require surgical correction when conservative management fails or the condition causes significant physical or psychological distress. This article explores the surgical techniques available, the suitability of local anaesthesia, what to expect during recovery, the associated risks, and how to access treatment through the NHS or privately in the UK.

Gynaecomastia Surgery: Procedure Options Available in the UK

Gynaecomastia surgery in the UK uses liposuction, glandular excision, or a combined approach depending on tissue composition and grade; preoperative hormonal and clinical assessment is essential before surgical referral.

Gynaecomastia — the benign enlargement of male breast tissue — affects a significant proportion of men at various life stages, from adolescence through to older adulthood. When conservative management fails or the condition causes persistent physical discomfort or psychological distress, surgical intervention may be considered. In the UK, two primary surgical techniques are used:

• Liposuction: Suitable when excess fatty tissue is the predominant component. A small cannula is inserted through a minor incision to remove fat.

• Mastectomy (glandular excision): Indicated when firm glandular breast tissue is present. This involves direct excision through a periareolar or inframammary incision.

• Combined approach: Many surgeons use both techniques simultaneously, particularly in Grade II or III gynaecomastia, to achieve a flat, contoured chest.

The choice of technique depends on the underlying tissue composition, the grade of gynaecomastia (commonly classified using the Simon or Rohrich grading systems), and the patient's overall health.

Preoperative assessment is essential before surgery is planned and should include:

• Hormonal blood tests: testosterone, LH, FSH, oestradiol, prolactin, TSH, and serum hCG

• Liver function tests

• Clinical examination of the testes; testicular ultrasound if a tumour is suspected

• Breast imaging (ultrasound or mammography) where clinically indicated

• A review of any causative medications

NICE CKS guidance on gynaecomastia emphasises that any underlying medical cause — such as hypogonadism, liver disease, thyroid dysfunction, or drug-induced gynaecomastia — should be identified and addressed prior to surgical referral.

Important: Men presenting with a unilateral, hard, or rapidly enlarging breast lump, nipple discharge, skin tethering, or axillary lymphadenopathy should be referred urgently via the two-week-wait pathway for suspected male breast cancer, in line with NICE NG12 (Suspected Cancer: Recognition and Referral).

The procedure is usually performed as day-case surgery, though this depends on the anaesthetic approach, the extent of the procedure, and the patient's individual health status and the facility's capability.

When Local Anaesthesia May Be Suitable for Gynaecomastia Surgery

Local anaesthesia is appropriate for mild to moderate gynaecomastia requiring primarily liposuction; extensive glandular excision or high patient anxiety generally warrants general anaesthesia instead.

Yes, gynaecomastia surgery can be performed under local anaesthesia in carefully selected patients, and this approach is offered by some specialist plastic and cosmetic surgeons across the UK. However, its suitability depends on several clinical and anatomical factors.

Local anaesthesia is generally considered appropriate when:

• The gynaecomastia is mild to moderate (Grade I or early Grade II)

• The procedure involves primarily liposuction with minimal glandular excision

• The patient is medically fit, cooperative, and able to tolerate the procedure whilst awake

• The planned procedure is limited in scope and duration

In practice, local anaesthesia is often combined with the tumescent technique — a method in which dilute lidocaine and adrenaline solution is infiltrated into the treatment area. This reduces bleeding, improves tissue separation, and prolongs postoperative analgesia. Local anaesthetic dosing must follow BNF guidance and local protocols to avoid exceeding safe limits. Some surgeons also offer conscious sedation alongside local anaesthesia, allowing the patient to remain relaxed but responsive throughout.

Where conscious sedation is used, the facility must comply with the standards set out by the Royal College of Anaesthetists (RCoA) and the Academy of Medical Royal Colleges (AoMRC) for safe sedation practice in adults. This includes appropriate patient monitoring, airway rescue competencies, and the immediate availability of resuscitation equipment and trained personnel.

Conversely, general anaesthesia is more appropriate for extensive glandular excision, bilateral procedures with significant tissue volume, patients with needle phobia or high anxiety, or those with complex anatomy.

Patients should discuss their preferences openly with their surgeon during the consultation. The decision should be made jointly, based on clinical suitability rather than cost or convenience alone. Surgeons using local anaesthetics must ensure protocols are in place for the recognition and management of local anaesthetic systemic toxicity (LAST), including the immediate availability of intralipid emulsion, in line with Association of Anaesthetists guidance. Facilities must meet CQC registration standards and comply with RCS England Professional Standards for Cosmetic Surgery.

What to Expect During and After the Procedure

Under local anaesthesia patients remain awake, feeling pressure but not significant pain; recovery involves wearing a compression vest for 4–6 weeks, with final results visible at three to six months.

Understanding what the procedure involves helps patients make informed decisions and manage their recovery effectively. When performed under local anaesthesia, the patient remains awake throughout. The surgeon will first administer the local anaesthetic — typically lidocaine with adrenaline — via a series of small injections into the chest area. Patients may feel pressure, movement, or mild discomfort, but significant pain should not be experienced. If it is, additional anaesthetic can be administered.

During the procedure:

• Small incisions (usually 3–5 mm for liposuction ports, or a periareolar incision for excision) are made

• Liposuction is performed using a fine cannula; glandular tissue is excised with surgical instruments if required

• Any excised glandular tissue is routinely sent for histopathological examination

• The area is then closed with sutures, and a compression garment is applied

Postoperative recovery typically involves:

• Wearing a compression vest for 4–6 weeks to reduce swelling and support healing

• Mild to moderate soreness, bruising, and swelling for 2–4 weeks

• Taking analgesia as directed by your surgeon (typically paracetamol and/or ibuprofen unless contraindicated)

• Following wound-care instructions provided by your surgical team, including guidance on showering and dressing changes

• Returning to light activities within a few days, and more strenuous exercise after 4–6 weeks

• Driving: do not drive for at least 24 hours after sedation or general anaesthesia, and follow your surgeon's specific advice; check with your motor insurer if in doubt

• Follow-up appointments at 1–2 weeks and again at 6–12 weeks to assess healing

Seek urgent medical attention if you experience:

• Signs of infection: increasing redness, warmth, discharge, or fever

• Sudden worsening of pain or significant swelling

• Signs of deep vein thrombosis (DVT) or pulmonary embolism: leg swelling, redness or pain in the calf, chest pain, or breathlessness — call 999 or go to your nearest A&E

Numbness around the nipple–areola complex is common and usually resolves within several months, though in rare cases it may be permanent. Final results are typically visible at three to six months once swelling has fully subsided.

Risks, Limitations, and Safety Considerations

Key risks include haematoma, infection, scarring, asymmetry, and local anaesthetic systemic toxicity (LAST); facilities must hold CQC registration and surgeons should be on the GMC Specialist Register.

As with any surgical procedure, gynaecomastia surgery carries inherent risks, and patients should receive a thorough, balanced discussion of these before providing informed consent. The Royal College of Surgeons of England (RCS) and the General Medical Council (GMC) both emphasise the importance of transparent risk communication and shared decision-making in cosmetic surgery.

General surgical risks include:

• Haematoma (blood pooling beneath the skin) — one of the more common early complications

• Seroma (fluid accumulation)

• Wound infection and delayed wound healing

• Scarring, including hypertrophic or keloid scars in predisposed individuals

• Asymmetry or contour irregularities

• Changes in nipple sensation (temporary or permanent)

• Nipple–areolar or skin necrosis (rare)

• Skin redundancy, particularly in older patients or those with significant tissue excess

• Venous thromboembolism (VTE), including DVT and pulmonary embolism

• The possible need for revision surgery

Specific to local anaesthesia, there is a risk of local anaesthetic systemic toxicity (LAST) if excessive volumes are administered without careful dosing. Symptoms include dizziness, tinnitus, perioral tingling, and in severe cases, cardiac arrhythmia or seizure. In line with Association of Anaesthetists guidance, reputable surgical facilities must have LAST management protocols in place, including the immediate availability of intralipid emulsion and trained staff capable of resuscitation, as required by CQC registration standards.

A notable limitation of local anaesthesia is that patient movement or discomfort during the procedure may compromise surgical precision, particularly during glandular excision. There is also a risk of incomplete resection if the patient cannot tolerate the full extent of the planned procedure whilst awake.

The risks associated with gynaecomastia surgery depend on the individual patient, the procedure performed, and the competence of the surgical team and facility. Patients should ensure their surgeon is on the GMC Specialist Register and that the facility holds appropriate CQC registration. The Independent Review of the Regulation of Cosmetic Interventions (Keogh Review, 2013) continues to inform best practice standards in the UK, alongside RCS England Professional Standards for Cosmetic Surgery and GMC guidance for doctors who offer cosmetic interventions.

Yellow Card reporting: If you experience a suspected reaction to a medicine or medical device used during your procedure — such as a local anaesthetic — this can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Accessing Gynaecomastia Treatment Through the NHS or Privately

NHS funding for gynaecomastia surgery is limited, as most ICBs classify it as low clinical priority; private treatment typically costs £3,000–£6,000, with a recommended two-week cooling-off period before proceeding.

Access to gynaecomastia surgery in the UK depends on whether the condition is deemed to have a clinical or primarily cosmetic basis. Understanding the distinction is important for patients navigating their options.

NHS access is generally limited and subject to strict eligibility criteria. Most Integrated Care Boards (ICBs) — which replaced Clinical Commissioning Groups — classify gynaecomastia surgery as a procedure of low clinical priority, meaning it is not routinely funded. Eligibility criteria and funding decisions vary by local ICB policy; patients who do not meet standard criteria may be able to apply through an Individual Funding Request (IFR) process. Exceptions may be made where:

• There is a clearly identified underlying medical cause (e.g., a hormone-secreting tumour)

• The condition causes significant, documented psychological harm (some ICBs require this to be assessed using recognised tools)

• The patient is an adolescent with persistent, severe gynaecomastia that has not resolved naturally

Patients seeking NHS assessment should begin with their GP, who can arrange relevant investigations in line with NICE CKS guidance on gynaecomastia — including testosterone, LH, FSH, oestradiol, prolactin, TSH, hCG, and liver function tests — and refer to an endocrinologist or general surgeon if appropriate.

Private treatment is the more common route for surgical correction in the UK. Costs typically range from approximately £3,000 to £6,000, though this is indicative only and varies considerably depending on the technique used, the surgeon's experience, and the geographic location of the clinic. Patients considering private surgery should:

• Ensure the surgeon is GMC-registered with a specialist interest in plastic or cosmetic surgery; membership of BAAPS or BAPRAS may provide additional assurance

• Request a face-to-face consultation before committing to any procedure

• Allow a two-week cooling-off period between consultation and surgery, as recommended by the Keogh Review (2013) and RCS England Professional Standards for Cosmetic Surgery

• Obtain written information about the procedure, risks, and aftercare in line with GMC guidance on cosmetic interventions

Whether accessing care through the NHS or privately, patients are encouraged to approach the decision thoughtfully, seek second opinions where uncertain, and prioritise safety over cost.

Frequently Asked Questions